Press Release
Walden Biosciences Expands Research Collaboration with the University of Michigan
January 10, 2024
Walden Biosciences to Host Virtual Event on November 14, 2023 “Transforming the Treatment Landscape of Chronic Kidney Disease”
November 7, 2023
Walden Biosciences Announces First Subject Dosed in First-in-Humans Phase 1 Clinical Trial of WAL0921, in Development for Treatment of Chronic Kidney Diseases
June 5, 2023
Walden Biosciences Promotes Curt Dewan, CFA to Chief Financial Officer
April 5, 2023
Walden Biosciences Announces Presentation at the Oppenheimer 33rd Annual Healthcare Conference
March 9, 2023
Walden Biosciences To Present at 5th Annual Chronic Kidney Disease Drug Development Summit
March 8, 2023
